Atria Investments LLC Increases Position in Intuitive Surgical, Inc. (ISRG)

Atria Investments LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 189.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,777 shares of the medical equipment provider’s stock after purchasing an additional 1,163 shares during the period. Atria Investments LLC’s holdings in Intuitive Surgical were worth $648,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Stifel Financial Corp boosted its holdings in shares of Intuitive Surgical by 11.2% in the second quarter. Stifel Financial Corp now owns 8,356 shares of the medical equipment provider’s stock valued at $7,837,000 after purchasing an additional 841 shares during the period. First Trust Advisors LP boosted its holdings in shares of Intuitive Surgical by 61.4% in the third quarter. First Trust Advisors LP now owns 51,130 shares of the medical equipment provider’s stock valued at $53,476,000 after purchasing an additional 19,458 shares during the period. Davis R M Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $219,000. Point72 Asset Management L.P. purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $24,264,000. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Intuitive Surgical by 122.0% in the second quarter. Tower Research Capital LLC TRC now owns 819 shares of the medical equipment provider’s stock valued at $766,000 after purchasing an additional 450 shares during the period. Hedge funds and other institutional investors own 33.11% of the company’s stock.

Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at $433.94 on Tuesday. The stock has a market capitalization of $48,620.00, a price-to-earnings ratio of 56.06, a PEG ratio of 5.17 and a beta of 0.47. Intuitive Surgical, Inc. has a 12-month low of $217.19 and a 12-month high of $436.57.

In related news, COO Salvatore Brogna sold 6,082 shares of the company’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $397.61, for a total value of $2,418,264.02. Following the transaction, the chief operating officer now directly owns 3,096 shares of the company’s stock, valued at approximately $1,231,000.56. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Craig H. Barratt sold 7,500 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were sold at an average price of $381.00, for a total value of $2,857,500.00. Following the completion of the transaction, the insider now directly owns 7,500 shares in the company, valued at $2,857,500. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 36,121 shares of company stock worth $14,074,068. Insiders own 2.20% of the company’s stock.

A number of analysts recently issued reports on the company. Leerink Swann reiterated an “outperform” rating and issued a $475.00 price target (up previously from $390.00) on shares of Intuitive Surgical in a report on Thursday, January 18th. BidaskClub upgraded Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a report on Thursday, January 11th. Barclays restated an “overweight” rating and set a $465.00 target price on shares of Intuitive Surgical in a report on Thursday, January 11th. Goldman Sachs Group restated a “buy” rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Finally, Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $436.00 target price for the company in a report on Tuesday, November 14th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $368.71.

WARNING: This story was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://ledgergazette.com/2018/01/23/atria-investments-llc-increases-position-in-intuitive-surgical-inc-isrg.html.

Intuitive Surgical Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply